260 related articles for article (PubMed ID: 24720754)
1. Inhibiting glycogen synthase kinase-3 mitigates the hematopoietic acute radiation syndrome in mice.
Lee CL; Lento WE; Castle KD; Chao NJ; Kirsch DG
Radiat Res; 2014 May; 181(5):445-51. PubMed ID: 24720754
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting Glycogen Synthase Kinase-3 Mitigates the Hematopoietic Acute Radiation Syndrome in a Sex- and Strain-dependent Manner in Mice.
Daniel AR; Lee CL; Oh P; Luo L; Ma Y; Kirsch DG
Health Phys; 2020 Sep; 119(3):315-321. PubMed ID: 32175929
[TBL] [Abstract][Full Text] [Related]
3. A new class of molecular targeted radioprotectors: GSK-3beta inhibitors.
Thotala DK; Geng L; Dickey AK; Hallahan DE; Yazlovitskaya EM
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):557-65. PubMed ID: 20117291
[TBL] [Abstract][Full Text] [Related]
4. Thioredoxin mitigates radiation-induced hematopoietic stem cell injury in mice.
Sundaramoorthy P; Wang Q; Zheng Z; Jiao Y; Chen BJ; Doan PL; Chao NJ; Kang Y
Stem Cell Res Ther; 2017 Nov; 8(1):263. PubMed ID: 29141658
[TBL] [Abstract][Full Text] [Related]
5. Thrombopoietin mimetic stimulates bone marrow vascular and stromal niches to mitigate acute radiation syndrome.
Vercellino J; Małachowska B; Kulkarni S; Bell BI; Shajahan S; Shinoda K; Eichenbaum G; Verma AK; Ghosh SP; Yang WL; Frenette PS; Guha C
Stem Cell Res Ther; 2024 Apr; 15(1):123. PubMed ID: 38679747
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule inhibitor of glycogen synthase kinase 3β 6-Bromoindirubin-3-oxime inhibits hematopoietic regeneration in stem cell recipient mice.
Shen S; Xu N; Klamer G; Ko KH; Khoo M; Ma D; Moore J; O'Brien TA; Dolnikov A
Stem Cells Dev; 2015 Mar; 24(6):724-36. PubMed ID: 25329250
[TBL] [Abstract][Full Text] [Related]
7. Single-Dose Administration of Recombinant Human Thrombopoietin Mitigates Total Body Irradiation-Induced Hematopoietic System Injury in Mice and Nonhuman Primates.
Xing S; Shen X; Yang JK; Wang XR; Ou HL; Zhang XW; Xiong GL; Shan YJ; Cong YW; Luo QL; Yu ZY
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1357-1367. PubMed ID: 32758640
[TBL] [Abstract][Full Text] [Related]
8. Filgrastim for the treatment of hematopoietic acute radiation syndrome.
Farese AM; MacVittie TJ
Drugs Today (Barc); 2015 Sep; 51(9):537-48. PubMed ID: 26488033
[TBL] [Abstract][Full Text] [Related]
9. Delayed Captopril Administration Mitigates Hematopoietic Injury in a Murine Model of Total Body Irradiation.
McCart EA; Lee YH; Jha J; Mungunsukh O; Rittase WB; Summers TA; Muir J; Day RM
Sci Rep; 2019 Feb; 9(1):2198. PubMed ID: 30778109
[TBL] [Abstract][Full Text] [Related]
10. A GSK-3β inhibitor protects against radiation necrosis in mouse brain.
Jiang X; Perez-Torres CJ; Thotala D; Engelbach JA; Yuan L; Cates J; Gao F; Drzymala RE; Rich KM; Schmidt RE; Ackerman JJ; Hallahan DE; Garbow JR
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):714-21. PubMed ID: 24969790
[TBL] [Abstract][Full Text] [Related]
11. The triterpenoid RTA 408 is a robust mitigator of hematopoietic acute radiation syndrome in mice.
Goldman DC; Alexeev V; Lash E; Guha C; Rodeck U; Fleming WH
Radiat Res; 2015 Mar; 183(3):338-44. PubMed ID: 25738896
[TBL] [Abstract][Full Text] [Related]
12. Optimizing and Profiling Prostaglandin E2 as a Medical Countermeasure for the Hematopoietic Acute Radiation Syndrome.
Patterson AM; Wu T; Chua HL; Sampson CH; Fisher A; Singh P; Guise TA; Feng H; Muldoon J; Wright L; Plett PA; Pelus LM; Orschell CM
Radiat Res; 2021 Feb; 195(2):115-127. PubMed ID: 33302300
[TBL] [Abstract][Full Text] [Related]
13. The protective effects of 1,2-propanediol against radiation-induced hematopoietic injury in mice.
Yi L; Tian M; Piao C; Gao G; Wu L; Pan Y; Liu J
Biomed Pharmacother; 2019 Jun; 114():108806. PubMed ID: 30928804
[TBL] [Abstract][Full Text] [Related]
14. Ex vivo culture rescues hematopoietic stem cells with long-term repopulating capacity following harvest from lethally irradiated mice.
Chute JP; Fung J; Muramoto G; Erwin R
Exp Hematol; 2004 Mar; 32(3):308-17. PubMed ID: 15003317
[TBL] [Abstract][Full Text] [Related]
15. Effects of captopril against radiation injuries in the Göttingen minipig model of hematopoietic-acute radiation syndrome.
Rittase WB; McCart EA; Muir JM; Bouten RM; Slaven JE; Mungunsukh O; Bylicky MA; Wilkins WL; Lee SH; Gudmundsson KO; Di Pucchio T; Olsen CH; Du Y; Day RM
PLoS One; 2021; 16(8):e0256208. PubMed ID: 34449797
[TBL] [Abstract][Full Text] [Related]
16. Survival efficacy of the PEGylated G-CSFs Maxy-G34 and neulasta in a mouse model of lethal H-ARS, and residual bone marrow damage in treated survivors.
Chua HL; Plett PA; Sampson CH; Katz BP; Carnathan GW; MacVittie TJ; Lenden K; Orschell CM
Health Phys; 2014 Jan; 106(1):21-38. PubMed ID: 24276547
[TBL] [Abstract][Full Text] [Related]
17. FSL-1: A Synthetic Peptide Increases Survival in a Murine Model of Hematopoietic Acute Radiation Syndrome.
Holmes-Hampton GP; Kumar VP; Valenzia K; Ghosh SP
Radiat Res; 2024 May; 201(5):449-459. PubMed ID: 38373011
[TBL] [Abstract][Full Text] [Related]
18.
Chang J; Feng W; Wang Y; Allen AR; Turner J; Stewart B; Raber J; Hauer-Jensen M; Zhou D; Shao L
Life Sci Space Res (Amst); 2017 May; 13():39-44. PubMed ID: 28554508
[TBL] [Abstract][Full Text] [Related]
19. GSK-3β inhibition promotes engraftment of ex vivo-expanded hematopoietic stem cells and modulates gene expression.
Ko KH; Holmes T; Palladinetti P; Song E; Nordon R; O'Brien TA; Dolnikov A
Stem Cells; 2011 Jan; 29(1):108-18. PubMed ID: 20960517
[TBL] [Abstract][Full Text] [Related]
20. Further Characterization of Multi-Organ DEARE and Protection by 16,16 Dimethyl Prostaglandin E2 in a Mouse Model of the Hematopoietic Acute Radiation Syndrome.
Wu T; Pelus LM; Plett PA; Sampson CH; Chua HL; Fisher A; Feng H; Liu L; Li H; Ortiz M; Chittajallu S; Luo Q; Bhatwadekar AD; Meyer TB; Zhang X; Zhou D; Fischer KD; McKinzie DL; Miller SJ; Orschell CM
Radiat Res; 2023 May; 199(5):468-489. PubMed ID: 37014943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
